News Archive
WASHINGTON (Sept. 24, 2019) - PTEN, a tumor suppressor gene mutated in approximately 20% of primary prostate cancers, and in as many as 50% of androgen deprivation-resistant prostate cancers, relies on another gene, ARID4B, to function.
Dr. Rengifo-Pardo is an accomplished dermatologist and clinical instructor of dermatology at the GW School of Medicine and Health Sciences. She also serves as clinical research coordinator at the GW Cancer Center.
WASHINGTON (Aug. 16, 2019) - The extracellular regulated kinase (ERK) protein is an important mechanism behind platinum-resistance in platinum-resistant ovarian cancer, according to a study from a research team at the George Washington University (GW) Cancer Center.
Eduardo Sotomayor, an internationally recognized visionary in the field of lymphoma research and treatment, was recently installed as the inaugural Dr. Cyrus Katzen Family Director of the George Washington University Cancer Center.
An estimated 850,000 to 2.2 million people in the United States are living with Chronic Hepatitis B. A research team from the George Washington University (GW) received a $1.5 million grant from the Office of Minority Health of the U.S. Department of Health & Human Services (HHS) to reduce…
The George Washington University (GW) is pleased to announce that the GW Biorepository is now a core facility.
Under the leadership of Vishal A. Patel, MD, FAAD, FACMS, director of the Cutaneous Oncology Program at the George Washington University (GW) Cancer Center, the GW Cancer Center was selected as the first global site for a clinical trial for patients with high-risk cutaneous squamous cell…
Dr. Patel is an accomplished Mohs/dermatologic surgeon and dermatologic oncologist. He also serves as director of the cutaneous oncology program at the GW Cancer Center, which brings together dermatologists, dermatologic surgeons, medical, surgical and radiation oncologists, and dermato-…
Milken Institute School of Public Health (Milken Institute SPH) at the George Washington University (GW) and the GW Cancer Center today announced that Carla J. Berg, PhD, MBA, has been named the associate center director for population sciences and policy for the GW Cancer Center. Berg, who…
Joel was diagnosed with stage 4 oral cancer. He decided to get cancer treatment at The George Washington University Hospital.